全球 Bracamesin 市场：按给药途径、按应用、按分销管道、按地区

2026年，全球布拉卡美辛市场价值将达到8.222亿美元，预计2031年将达到9.924亿美元，2026年至2031年的年复合成长率为3.8%。

图 1. Bracamesin全球市场占有率（%），依地区划分，2026 年

Bralcamesin 是细胞内 sigma-1Chaperone蛋白的促效剂。具体来说，它是混合的σ1/毒蕈碱受体配体。 sigma 1受体在大多数组织中表达，位于粒线体和内质网之间的局部接触处，与许多其他膜受体形成异二聚体，产生多种细胞路径，并影响生理过程。据报导，Bralcamesin 在高纳摩尔范围内与 sigma-1 受体结合，在低微摩尔范围内与毒蕈碱受体结合。据报道，这种化合物在接受毒蕈碱受体拮抗剂东莨菪碱、合成 AB寡聚物注射液和 NMDA 受体促效剂地佐西平治疗的小鼠中表现出记忆保留和神经保护作用（Villard 等） AB 使用寡聚物注射模型的其他研究表明，bralcamesin可能抑制Tau过度磷酸化并保护粒线体。

市场动态：.

政府批准的增加预计将在预测期内推动市场成长。例如，2023年12月19日，开发治疗神经退化性疾病和神经发育障碍的差异化疗法的临床阶段生物製药公司Anavex Lifesciences宣布，欧洲药品管理局（European Medicines Agency）人类使用医药产品委员会（ EMA 内的CHMP）宣布，已同意用于治疗阿兹海默症的口服 Bralcamesin 有资格根据欧洲药品管理局的集中程序在欧盟提交行销核准申请。

本研究的主要特点

• 该报告对全球 Bracamesin 市场进行了详细分析，并介绍了以 2023 年为基准年的预测期（2026-2031）的市场规模和年复合成长率（CAGR %）。
• 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球 Bralcamesin 市场的主要企业。
• 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球布拉卡机器市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
• 相关人员可以透过分析全球布拉马辛市场时所使用的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
• 主要亮点
• 监管场景
• 最近的趋势
• PEST分析
• 波特的分析
• 合併、收购和合作

第四章全球 Bralcamesin 市场 - 冠状病毒 (COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球 Bracalcamesin 市场，依给药途径，2019-2031

• 口服
• 胃肠外的

第六章 全球黑色摄影机市场，依应用分类，2019-2031

• 阿兹海默症
• 帕金森氏症
• 失智症
• 雷特氏症候群
• 其他的

第七章 全球黑机市场，2019-2031

• 医院药房
• 零售药房
• 网路药房

第8章全球黑来机市场，按地区，2019-2031

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第9章 竞争格局

• 公司简介
  • Anavex Life Sciences

第10章

• 参考
• 调查方法
• 关于出版商

Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2026 to 2031.

Figure 1. Global Blarcamesine Market Share (%), By Region, 2026

Blarcamesine is an agonist of the intracellular sigma-1 chaperone protein. Specifically, it is a mixed ligand for sigma1/muscarinic receptors. Expressed in most tissues and located at focal contacts between mitochondria and the endoplasmic reticulum, the sigma-1 receptor forms heterodimers with many other membrane receptors and, as such, influences multiple cellular pathways and physiological processes. Blarcamesine reportedly binds the sigma-1 receptor in the high nanomolar and the muscarinic receptor in the low micromolar range. The compound has been reported to have memory-preserving and neuroprotective effects in mice treated with the muscarinic receptor antagonist scopolamine, with synthetic AB oligomer injection, or with the NMDA receptor agonist dizocilpine (Villard et al., 2011). Other studies in the AB oligomer injection model suggest that blarcamesine may block tau hyperphosphorylation and protect mitochondria.

Market Dynamics:

Increasing government approval is expected to drive the growth of the market over the forecast period. For instance, on December 19, 2023, Anavex Life Sciences, a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, announced that the Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency (EMA) agreed that oral blarcamesine for Alzheimer's disease is eligible for submission of an application for a Union Marketing Authorization in the EU under the European Medicines Agency's centralized procedure.

Key features of the study:

• This report provides in-depth analysis of the global blarcamesine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2026-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blarcamesine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Anavex Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global blarcamesine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blarcamesine market

Detailed Segmentation:

• Global Blarcamesine Market, By Route of Administration
  • Oral
  • Parentral
• Global Blarcamesine Market, By Application
  • Alzheimer's Disease
  • Parkinson's Disease
  • Dementia
  • Rett Syndrome
  • Others
• Global Blarcamesine Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Blarcamesine Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Top Companies in the Global Blarcamesine Market:
  • Anavex Life Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Blarcamesine Market, By Route of Administration
  • Global Blarcamesine Market, By Application
  • Global Blarcamesine Market, By Distribution Channel
  • Global Blarcamesine Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing research and development activities
  • Strict regulatory requirements
  • Emerging markets
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Blarcamesine Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Blarcamesine Market, By Route of Administration, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Blarcamesine Market, By Application, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Alzheimer's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Parkinson's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Dementia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Rett Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Blarcamesine Market, By , 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Blarcamesine Market, By Region, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, For Region,
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profile
  • Anavex Life Sciences
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us